<sup>99</sup>Tc<sup>m</sup>-MIBI SPECT/CT显像在原发性甲状旁腺功能亢进症诊断中的价值讨论

doi:10.13491/j.issn.1004-714x.2019.02.022

中国辐射卫生

2019, Vol. 28

Issue (2): 194-197 DOI: 10.13491/j.issn.1004-714x.2019.02.022

诊断与治疗/论著

本期目录 | 过刊浏览 | 高级检索

⁹⁹Tc^m-MIBI SPECT/CT显像在原发性甲状旁腺功能亢进症诊断中的价值讨论

李帝^1,2,3, 张琳², 邓大平²

1. 山东省医学科学院医学与生命科学学院, 山东济南 250200;
2. 山东省医学科学院放射医学研究所;
3. 济宁市第一人民医院核医学科

Discussion on the value of ⁹⁹Tc^m-MIBI single photon emission computed tomography/computerized tomography in the diagnosis of primary hyperparathyroidism

LI Di^1,2,3, ZHANG Lin², DENG Daping²

1. School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250200 China;
2. Institute of Radiation Medicine, Shandong Academy of Medical Sciences;
3. Department of Nuclear Medicine, Jining No.1 hosptial

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (845 KB) HTML ( )
输出: BibTeX | EndNote (RIS)

摘要目的探讨⁹⁹Tc^m-MIBI SPECT/CT显像在原发性甲状旁腺功能亢进症（PHPT）中的诊断价值。方法回顾性分析为诊断PHPT而行⁹⁹Tc^m-MIBI SPECT/CT显像检查的57例患者的临床资料，以术后病理诊断为金标准，与高频超声、CT结果对比，分别统计三种检查方法的灵敏度、特异度、诊断符合率，将三种检查方法的灵敏度、特异度、诊断符合率加以对比分析。结果 57例病人经手术及病理检查共确诊76个PHPT病灶。⁹⁹Tc^m-MIBI SPECT/CT显像、高频超声、CT敏感度分别为75%、69.73%、50.94%；特异度分别为93.75%、96.07%、95.08%；诊断符合率分别为83.57%、80.31%、74.56%。⁹⁹Tc^m-MIBI SPECT/CT显像敏感度、诊断符合率高于CT （P<0.05），⁹⁹Tc^m-MIBI SPECT/CT显像对异位PHPT病灶诊断的敏感度为100%。结论 ⁹⁹Tc^m-MIBI SPECT/CT显像在PHPT病灶的定位中有较高的价值，是术前定位的较好方法。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	李帝
	张琳
	邓大平

关键词 ： ⁹⁹Tc^m-MIBI SPECT/CT显像, 高频超声, CT, 原发性甲状旁腺功能亢进症

收稿日期: 2018-12-23

PACS:

R817.7

通讯作者: 邓大平,E-mail:yanzhid@126.com E-mail: yanzhid@126.com

作者简介: 李帝(1988-),男,山东济宁人,在读硕士研究生,从事核医学工作,E-mail:lidijia2011@163.com

引用本文:

李帝, 张琳, 邓大平. ⁹⁹Tc^m-MIBI SPECT/CT显像在原发性甲状旁腺功能亢进症诊断中的价值讨论[J]. 中国辐射卫生, 2019, 28(2): 194-197.
LI Di, ZHANG Lin, DENG Daping. Discussion on the value of ⁹⁹Tc^m-MIBI single photon emission computed tomography/computerized tomography in the diagnosis of primary hyperparathyroidism. , 2019, 28(2): 194-197.

链接本文:

http://www.zgfsws.com/CN/10.13491/j.issn.1004-714x.2019.02.022 或 http://www.zgfsws.com/CN/Y2019/V28/I2/194

[1] Hindié E, Zanotti-Fregonara P, Tabarin A, et al. The role of radionuclide imaging in the surgical management of primary hyperparathyroidism[J]. Journal of Nuclear Medicine, 2015,56(5):737-744.
[2] Yeh M W, Ituarte P H, Zhou H C, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population[J]. The Journal of Clinical Endocrinology & Metabolism, 2013, 98(3):1122-1129.
[3] 黎俊,李莉,林华. ⁹⁹Tc^m-MIBI双时相显像与SPECT/CT融合显像对原发性甲状旁腺功能亢进症的诊断价值[J].医学影像学杂志,2017,27(6):1063-1067.
[4] 朱进,柴雪红.高频彩超联合⁹⁹Tc^m-MIBI双时显像诊断原发性甲状旁腺功能亢进的价值[J].中国医学工程,2015,23(1):17-18.
[5] 卢峰,宋钢,李全太,等.SPECT设备性能测试及结果分析[J].中国辐射卫生,2014,23(1):26-28.
[6] 陈维安,崔颖鹏,李春亿,等.⁹⁹Tc^m-MIBI双时相显像诊断甲状旁腺功能亢进的临床价值[J].中国临床医学影像杂志, 2006,17(3):146-147, 157.
[7] Piga M, Bolasco P, Satta L, et al. Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism[J]. J Nucl Med, 1996,37(4):565-569.
[8] Hetrakul N, Civelek A C, Stagg C A, et al. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria[J]. Surgery, 2001,130(6):1011-1018.
[9] Turgut B, Elagoz S, Erselcan T, et al. Preoperative localization of parathyroid adenomas with technetium-99m methoxyisobutylisonitrile imaging:relationship with P-glycoprotein expression, oxyphilic cell content, and tumoral tissue volume[J]. Cancer Biotherapy and Radiopharmaceuticals,2006,21(6):579-590.
[10] Traub-Weidinger T, Mayerhoefer M E, Koperek O, et al. 11C-methionine PET/CT imaging of⁹⁹Tc^m-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery[J]. The Journal of Clinical Endocrinology & Metabolism, 2014, 99(11):4199-4205.
[11] 池晓华,王全师,李贵平,等.⁹⁹Tc^m-MIBI双时相显像在甲状旁腺素增高患者中的应用[J].中华全科医学,2017,15(2):202-205.
[12] 黄甜,洪文明,季丽华,等.误诊为甲状腺微小乳头状癌的良性小结节超声与病理结果对比分析[J].中国辐射卫生,2017,26(6):723-725,729.
[13] 陆凤华,张琍萍,张雅红.高频超声对甲状旁腺功能亢进的诊断价值[J].现代实用医学,2017,29(3):385-386.
[14] 白永利,王林,董莉.⁹⁹Tc^m-MIBI显像在原发性甲状旁腺功能亢进定位诊断中的应用价值[J].现代肿瘤医学,2016,24(9):1368-1371.
[15] Kim Y I, Jung Y H, Hwang K T, et al. Efficacy of ⁹⁹Tc^m-sestamibi SPECT/CT for minimally invasive parathyroidectomy:comparative study with ⁹⁹Tc^m-sestamibi scintigraphy, SPECT, US and CT[J]. Ann Nucl Med, 2012, 26(10):804-810.
[16] 张永强,王昀璐,梁琰,等.¹⁸F-FDG SPECT/CT与64排CT异机融合在结直肠癌诊断中的应用[J].中国辐射卫生,2018,27(1):81-84.
[17] 宁玉东,王田田,薄少军,等.磁共振成像在继发性甲状旁腺功能亢进症术前定位的诊断价值[J].中国耳鼻咽喉头颈外科,2017,24(10):497-500.